The SA healthcare industry had an eventful 2023, starting with health minister Joe Phaahla announcing a 3.28% increase in the single exit price (SEP) of qualified pharmaceutical products.

In September 2023, a further 1.73% increase was announced. SEP is the price set by pharmaceutical manufacturers at which a medicine may be sold, including VAT and a logistics fee. Though the increases were welcomed, they were still deemed insufficient to fully offset inflation. Still, two of the biggest drug-makers in the country, Adcock Ingram and Aspen Pharmacare performed well on the stock market...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.